These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


182 related items for PubMed ID: 15881479

  • 1. Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery.
    Kim DH, Stark WJ, O'Brien TP.
    Curr Med Res Opin; 2005 Jan; 21(1):93-4. PubMed ID: 15881479
    [Abstract] [Full Text] [Related]

  • 2. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.
    Kim DH, Stark WJ, O'Brien TP, Dick JD.
    Ophthalmology; 2005 Nov; 112(11):1992-6. PubMed ID: 16183125
    [Abstract] [Full Text] [Related]

  • 3. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery.
    Ong-Tone L.
    J Cataract Refract Surg; 2008 May; 34(5):819-22. PubMed ID: 18471639
    [Abstract] [Full Text] [Related]

  • 4. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
    McCulley JP, Caudle D, Aronowicz JD, Shine WE.
    Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
    [Abstract] [Full Text] [Related]

  • 5. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
    Holland EJ, Lane SS, Kim T, Raizman M, Dunn S.
    Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
    [Abstract] [Full Text] [Related]

  • 6. Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery.
    Güngör SG, Akova YA, Bozkurt A, Yasar Ü, Babaoğlu MÖ, Çetinkaya A, Çolak M.
    Br J Ophthalmol; 2011 Sep; 95(9):1272-5. PubMed ID: 21030410
    [Abstract] [Full Text] [Related]

  • 7. Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients.
    Yoshida J, Kim A, Pratzer KA, Stark WJ.
    J Cataract Refract Surg; 2010 Sep; 36(9):1499-502. PubMed ID: 20692561
    [Abstract] [Full Text] [Related]

  • 8. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor.
    Solomon R, Donnenfeld ED, Perry HD, Snyder RW, Nedrud C, Stein J, Bloom A.
    Ophthalmology; 2005 Mar; 112(3):466-9. PubMed ID: 15745775
    [Abstract] [Full Text] [Related]

  • 9. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery.
    Ong-Tone L.
    J Cataract Refract Surg; 2007 Jan; 33(1):59-62. PubMed ID: 17189794
    [Abstract] [Full Text] [Related]

  • 10. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application.
    Donnenfeld ED, Comstock TL, Proksch JW.
    J Cataract Refract Surg; 2011 Jun; 37(6):1082-9. PubMed ID: 21596251
    [Abstract] [Full Text] [Related]

  • 11. Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty.
    Fukuda M, Yamada M, Kinoshita S, Inatomi T, Ohashi Y, Uno T, Shimazaki J, Satake Y, Maeda N, Hori Y, Nishida K, Kubota A, Nakazawa T, Shimomura Y.
    Adv Ther; 2012 Apr; 29(4):339-49. PubMed ID: 22529026
    [Abstract] [Full Text] [Related]

  • 12. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing.
    Levine JM, Noecker RJ, Lane LC, Herrygers L, Nix D, Snyder RW.
    J Cataract Refract Surg; 2004 Oct; 30(10):2177-82. PubMed ID: 15474833
    [Abstract] [Full Text] [Related]

  • 13. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
    Vasavada AR, Gajjar D, Raj SM, Vasavada V, Vasavada V.
    J Cataract Refract Surg; 2008 Aug; 34(8):1379-82. PubMed ID: 18655991
    [Abstract] [Full Text] [Related]

  • 14. Vitreous penetration of topical moxifloxacin and gatifloxacin in humans.
    Costello P, Bakri SJ, Beer PM, Singh RJ, Falk NS, Peters GB, Melendez JA.
    Retina; 2006 Feb; 26(2):191-5. PubMed ID: 16467677
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Conjunctival concentrations of a new ophthalmic solution formulation of moxifloxacin 0.5% in cataract surgery patients.
    Lindstrom R, Lane S, Cottingham A, Smith S, Sall K, Silverstein S, Shettle L, Walters T, Faulkner R, Cockrum P, Teuscher N.
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):591-5. PubMed ID: 20925517
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intraocular concentrations of gatifloxacin and moxifloxacin in the anterior chamber via diffusion through the cornea using collagen shields.
    Kleinmann G, Larson S, Neuhann IM, Hunold AC, LeBoyer R, Hickman S, Mamalis N, Olson RJ.
    Cornea; 2006 Feb; 25(2):209-13. PubMed ID: 16371785
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.